Alnylam Pharmaceuticals, INC.
Biopharmaceutical company
Based in MA
🤖
AI Overview
With $1.4M in lobbying spend across 30 quarterly filings, Alnylam Pharmaceuticals, INC. is a significant lobbying presence.
$1.4M
Total Lobbying Spend
30
Quarterly Filings
1
Lobbying Firms Used
10
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $60K |
| 2019 | $90K |
| 2020 | $90K |
| 2021 | $210K |
| 2022 | $200K |
| 2023 | $200K |
| 2024 | $300K |
| 2025 | $240K |
Lobbying Firms
TODD STRATEGY GROUP
What They Lobby For
- Medicare coverage and reimbursement.
- COVID-19 Response.
- Medicare coverage and reimbursement. Home infusion.
- Medicare coverage and reimbursement. Home infusion. Part B Rebates.
- Medicare coverage and reimbursement. Home infusion. H.R.5376 - Build Back Better Act. H.R.3684 - Infrastructure Investment and Jobs Act.
- Medicare coverage and reimbursement. Home Infusion. H.R.5376 - Build Back Better Act.
- Medicare coverage and reimbursement. Home Infusion. H.R.5376 - Build Back Better Act. FDA regulation of platform technologies.
- Medicare coverage and reimbursement. Home Infusion. H.R.5376 - Inflation Reduction Act of 2022. FDA regulation of platform technologies.
- Medicare and Medicaid Issues. MINI Act. ORPHAN Act. Food and Drug Omnibus Reform Act of 2022.
- Medicare and Medicaid Issues H.R.5547/S.476 - Maintaining Investments in New Innovation (MINI) Act. H.R.5539/S.3131 - ORPHAN Cures Act. Home Infusion.
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.